Company intelligence / Profile preview

KDB Asia

Ownership: Private
Development stage: Other

Overview

KDB Asia Limited is a wholly owned subsidiary of Korea Development Bank established to serve as its primary platform for corporate and investment banking activities across Asian markets from its base in Hong Kong. The firm provides "one-stop" financial solutions including corporate lending, project finance, securities services, and advisory—primarily targeting industrial development rather than any specific focus on biotechnology, pharmaceuticals, CROs/CMOs or healthcare sectors. There are no indications that it operates drug development programs or has clinical-stage assets relevant to life sciences.

Industry: Investors

Partnerships

No major pharmaceutical or biotech partnerships; focus is on financial and investment banking services.

Beyond the preview

Go deeper on KDB Asia.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on KDB Asia.

Explore the full profile